New study tracks organ health after sickle cell 'Cures'
NCT ID NCT05153967
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This study follows 750 people with sickle cell disease to see how curative therapies affect the heart, lungs, and kidneys over time. Researchers will compare those who received a stem cell transplant with those on standard treatment. The goal is to understand whether curative therapies improve or worsen organ damage, helping patients make better treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors and patients decide whether curative therapy or standard care is better for long-term heart, lung, and kidney health.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test a new drug or cure, and results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's National Medical Center
NOT_YET_RECRUITINGWashington D.C., District of Columbia, 20010, United States
-
Emory University School of Medicine
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
-
Johns Hopkins Hospital
NOT_YET_RECRUITINGBaltimore, Maryland, 21287, United States
-
National Institutes of Health Clinical Center
NOT_YET_RECRUITINGBethesda, Maryland, 20814, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232-9000, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Blood-Vessel drug shield weak hearts during surgery?
- Can a daily pill keep a rare heart disease in check for the long haul?
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- Can a new heart valve offer lasting relief for pulmonary stenosis?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?